Abbott's Amplatzer Paraclose PVL Occluder is the first heart device of its kind approved by the FDA to treat paravalvular leak. The agency made its decision after reviewing data from 200 patients who had undergone aortic or mitral valve replacement surgery.

Medtronic identified an issue with its CareLink SmartSync device manager providing inaccurate longevity estimates for certain leadless pacemakers. Customers can download a software update to resolve the issue going forward.

The Heart Failure Society of America has shard a new scientific statement calling for right heart failure to be recognized as its own distinct clinical syndrome instead of a secondary complication of left-sided heart disease.

Researchers tracked data from more than 50 million hospital discharges. Overall, legalizing recreational cannabis was linked to more patients being hospitalized for myocardial infarction, atrial fibrillation and heart failure.

The American Heart Association and three other leading medical societies want clinicians to consider the heart health of women during all stages of life, from adolescence to menopause and beyond.

The new device from Chicago-based Parasol Med Tech uses gel to seal the left atrial appendage. It leaves no metal hardware behind.

Cardiologists with Henry Ford Hospital recently performed pulmonary artery denervation on two adults with pulmonary hypertension. These were the first patients in the United States to undergo treatment as part of the global PULSE-LHD trial.

"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

The product at the heart of this recall is a dietary supplement taken to boost energy and performance when exercising. The FDA previously warned the public not to take it due to the potential side effects. 

Aetna is the latest to sue, pointing to re-used metrics that were discarded in a court victory by Clover Health. CMS is appealing that decision.

The facility, which will be located in Sanford, North Carolina, is expected to create 200 jobs across manufacturing, engineering, technical operations, quality, warehousing and administrative functions.